Schedule 13G ownership disclosure
Vir Biotechnology Inc
Security class unavailable · CUSIP: 92764N102
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 16,864,579
- Percent of class
- 12.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001086364-24-001765
- Form type
- SC 13G
- Filer
- BlackRock Finance, Inc.
- CIK
- CIK 1364742
- Filed
- Jan 23, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership